XML 13 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
Convertible Preferred Stock [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2023 $ (8,432,731)   $ 1,237 $ 707 $ 27,825,061 $ (36,259,736)
Beginning balance preferred stock, shares at Dec. 31, 2023     12,364,815      
Beginning balance common stock , shares at Dec. 31, 2023       7,072,300    
Retroactive application of recapitalization, shares     (2,159,935) (1,235,418)    
Retroactive application of recapitalization, amount     $ (217) $ (123) 340  
Net income (loss) $ (65,575,171)         (65,575,171)
Ending balance preferred stock, shares at Sep. 30, 2024   10,200,000 10,204,880      
Ending balance common stock, shares at Sep. 30, 2024 5,800,000     5,836,882    
Ending Balance at Sep. 30, 2024     $ 1,020 $ 584 27,825,401 (101,834,907)
Beginning Balance at Dec. 31, 2023 $ (8,432,731)   $ 1,237 $ 707 27,825,061 (36,259,736)
Beginning balance preferred stock, shares at Dec. 31, 2023     12,364,815      
Beginning balance common stock , shares at Dec. 31, 2023       7,072,300    
Ending balance preferred stock, shares at Dec. 31, 2024 10,204,880   10,204,880      
Ending balance common stock, shares at Dec. 31, 2024 5,836,882     5,836,882    
Ending Balance at Dec. 31, 2024 $ (67,808,929)   $ 1,020 $ 584 33,537,989 (101,348,522)
Beginning Balance at Jun. 30, 2024 (74,007,902)          
Net income (loss) $ (62,310,678)          
Ending balance preferred stock, shares at Sep. 30, 2024   10,200,000 10,204,880      
Ending balance common stock, shares at Sep. 30, 2024 5,800,000     5,836,882    
Ending Balance at Sep. 30, 2024     $ 1,020 $ 584 27,825,401 (101,834,907)
Beginning Balance at Dec. 31, 2024 $ (67,808,929)   $ 1,020 $ 584 33,537,989 (101,348,522)
Beginning balance preferred stock, shares at Dec. 31, 2024 10,204,880   10,204,880      
Beginning balance common stock , shares at Dec. 31, 2024 5,836,882     5,836,882    
Net income (loss) $ (34,899,390)         (34,899,390)
Reverse recapitalization, net of expenses, shares     (10,204,880) 39,163,783    
Reverse recapitalization, net of expenses, amount 173,824,440   $ (1,020) $ 3,916 173,821,544  
Share based compensation expense $ 8,470,932     $ 100 8,470,832  
Share based compensation expense,shares       995,599    
Exercise of Series B warrants       $ 50 (50)  
Exercise of Series B warrants, shares 500,000     500,000    
Issuance of March 2025 Closing Shares and Warrants $ 9,569,184     $ 75 9,569,109  
Issuance of March 2025 Closing Shares and Warrants, shares       750,000    
Change in fair value of Series C Warrants 498,771       498,771  
Issuance of interest shares 1,246,652     $ 25 1,246,627  
Issuance of interest shares , shares       248,070    
Issuance of placement shares 353,250     $ 8 353,242  
Issuance of Placement Shares       75,000    
Issuance of common stock $ 3,434,331     $ 115 3,434,216  
Issuance of common stock,share       1,151,071    
Ending balance preferred stock, shares at Sep. 30, 2025 0          
Ending balance common stock, shares at Sep. 30, 2025 48,018,545     48,720,405    
Ending Balance at Sep. 30, 2025 $ 94,689,241     $ 4,873 $ 230,932,280 $ (136,247,912)